What is the efficacy of the RTS,S malaria vaccine?

What is the efficacy of the RTS,S malaria vaccine?

Pokaż inne wersje (1)

Opis bibliograficzny
Główni autorzy:	Duncan, C, Hill, A
Format:	Journal article
Język:	English
Wydane:	2011

Podobne zapisy

THE RTS,S MALARIA VACCINE What is the efficacy of the RTS,S malaria vaccine?
od: Duncan, C, i wsp.
Wydane: (2011)

What is the efficacy of the RTS,S malaria vaccine?
od: Duncan, C, i wsp.
Wydane: (2011)

RTS,S/AS01 malaria vaccine in African children.
od: Hill, A
Wydane: (2012)

RTS,S: the first malaria vaccine
od: Fidel Zavala
Wydane: (2022-01-01)

Environmental modifiers of RTS,S/AS01 malaria vaccine efficacy in Lilongwe, Malawi
od: Griffin J. Bell, i wsp.
Wydane: (2020-06-01)

RTS,S Malaria Vaccine and Increased Mortality in Girls
od: Sabra L. Klein, i wsp.
Wydane: (2016-05-01)

The thermostability of the RTS,S/AS01 malaria vaccine can be increased by co-lyophilizing RTS,S and AS01
od: Juliette Fortpied, i wsp.
Wydane: (2020-06-01)

Seven year efficacy of RTS,S/AS01 malaria vaccine in young African children
od: Olotu, A, i wsp.
Wydane: (2016)

Efficacy of RTS,S malaria vaccines: individual-participant pooled analysis of phase 2 data.
od: Bejon, P, i wsp.
Wydane: (2013)

Efficacy of RTS,S malaria vaccines: Individual-participant pooled analysis of phase 2 data
od: Bejon, P, i wsp.
Wydane: (2013)

The RTS,S malaria vaccine: Journey from conception to recommendation
od: Oluwaseyi Muyiwa Egbewande
Wydane: (2022-12-01)

RTS,S malaria vaccine efficacy and immunogenicity during Plasmodium falciparum challenge is associated with HLA genotype
od: Nielsen, C, i wsp.
Wydane: (2018)

Efficacy of RTS,S/AS01E vaccine against malaria in children 5 to 17 months of age.
od: Bejon, P, i wsp.
Wydane: (2008)

Pre-erythrocytic malaria vaccines: RTS,S, R21, and beyond
od: Elizabeth Adrianne Hammershaimb, i wsp.
Wydane: (2024-12-01)

RTS,S/AS01E Vaccine against Malaria THE AUTHORS REPLY
od: Bejon, P, i wsp.
Wydane: (2009)

The future of the RTS,S/AS01 malaria vaccine: an alternative development plan
od: Gosling, R, i wsp.
Wydane: (2015)

The Future of the RTS,S/AS01 Malaria Vaccine: An Alternative Development Plan.
od: Roly Gosling, i wsp.
Wydane: (2016-04-01)

Efficacy of phase 3 trial of RTS, S/AS01 malaria vaccine: The need for an alternative development plan
od: Shima Mahmoudi, i wsp.
Wydane: (2017-09-01)

Potential effect modification of RTS,S/AS01 malaria vaccine efficacy by household socio-economic status
od: Stephaney Gyaase, i wsp.
Wydane: (2021-01-01)

Insights from modelling malaria vaccines for policy decisions: the focus on RTS,S
od: Katya Galactionova, i wsp.
Wydane: (2021-11-01)

Mosquirix™ RTS, S/AS01 Vaccine Development, Immunogenicity, and Efficacy
od: Aroosa Younis Nadeem, i wsp.
Wydane: (2022-04-01)

A combined analysis of immunogenicity, antibody kinetics and vaccine efficacy from phase 2 trials of the RTS,S malaria vaccine
od: White, M, i wsp.
Wydane: (2014)

Concentration and avidity of antibodies to different circumsporozoite epitopes correlate with RTS,S/AS01E malaria vaccine efficacy
od: Carlota Dobaño, i wsp.
Wydane: (2019-05-01)

Acceptance, availability, and feasibility of RTS, S/AS01 malaria vaccine: A review
od: Hassan Mumtaz, i wsp.
Wydane: (2023-06-01)

Implementation strategies for the introduction of the RTS,S/AS01 (RTS,S) malaria vaccine in countries with areas of highly seasonal transmission: workshop meeting report
od: Corinne S. Merle, i wsp.
Wydane: (2023-08-01)

The future of malaria control in light of RTS,S
od: Priya Venkatesan
Wydane: (2022-04-01)

Safety and high level efficacy of the combination malaria vaccine regimen of RTS,S/AS01B with ChAd-MVA vectored vaccines expressing ME-TRAP
od: Rampling, T, i wsp.
Wydane: (2016)

T cell responses to the RTS,S/AS01(E) and RTS,S/AS02(D) malaria candidate vaccines administered according to different schedules to Ghanaian children.
od: Daniel Ansong, i wsp.
Wydane: (2011-04-01)

Simulated impact of RTS,S/AS01 vaccination programs in the context of changing malaria transmission.
od: Alan Brooks, i wsp.
Wydane: (2012-01-01)

A phase 3 trial of RTS,S/AS01 malaria vaccine in African infants.
od: Agnandji, S, i wsp.
Wydane: (2012)

Costs of continuing RTS,S/ASO1E malaria vaccination in the three malaria vaccine pilot implementation countries.
od: Ranju Baral, i wsp.
Wydane: (2021-01-01)

Four-year efficacy of RTS,S/AS01E and its interaction with malaria exposure.
od: Olotu, A, i wsp.
Wydane: (2013)

Impact of RTS,S/AS02(A) and RTS,S/AS01(B) on genotypes of P. falciparum in adults participating in a malaria vaccine clinical trial.
od: John N Waitumbi, i wsp.
Wydane: (2009-11-01)

Correction: Randomized Controlled Trial of RTS,S/AS02 and RTS,S/AS01 Malaria Candidate Vaccines Given According to Different Schedules in Ghanaian Children.
od: Seth Owusu-Agyei, i wsp.
Wydane: (2010-01-01)

Influence of trust on the acceptance of the RTS,S malaria vaccine in the Kassena-Nankana districts of Ghana
od: Eustace Bugase, i wsp.
Wydane: (2024-11-01)

Characterization of T-cell immune responses in clinical trials of the candidate RTS,S malaria vaccine
od: Philippe Moris, i wsp.
Wydane: (2018-01-01)

Acceptance, availability and feasibility of RTS, S/AS01 malaria vaccine: A review of literature
od: Abdullah Nadeem, i wsp.
Wydane: (2023-01-01)

Towards Eradication of Malaria: Is the WHO’s RTS,S/AS01 Vaccination Effective Enough?
od: Arora N, i wsp.
Wydane: (2021-03-01)

Induction, decay, and determinants of functional antibodies following vaccination with the RTS,S malaria vaccine in young children
od: Gaoqian Feng, i wsp.
Wydane: (2022-08-01)

Further analysis of correlates of protection from a phase 2a trial of the falciparum malaria vaccines RTS,S/AS01B and RTS,S/AS02A in malaria-naive adults.
od: Olotu, A, i wsp.
Wydane: (2010)